ClinConnect ClinConnect Logo
Search / Trial NCT06974188

AI-Powered CURAᵀᴹ Application for Identifying At-Risk Pregnancies in Obstetric Management

Launched by NATIONAL UNIVERSITY HOSPITAL, SINGAPORE · May 8, 2025

Trial Information

Current as of July 23, 2025

Not yet recruiting

Keywords

Machine Learning Artificial Intelligence Antenatal Risk Stratification Software As A Medical Device Machine Learning Algorithm Pregnancy Complications Neonatal Complications Pregnancy Outcomes Obstetric Complications Antenatal Care

ClinConnect Summary

The clinical trial titled "AI-Powered CURAᵀᴹ Application for Identifying At-Risk Pregnancies in Obstetric Management" is studying how using artificial intelligence (AI) can help doctors better identify which pregnancies are at higher risk. By improving the way pregnancies are screened, the goal is to ensure that women receive the right care early on, which could lead to better health outcomes for both mothers and their babies.

To participate in this study, women need to be between 21 and 50 years old and must be pregnant with only one baby. They should be no more than 13 weeks and 6 days along in their pregnancy at the time they join the trial. Participants will need to understand English since the AI tools being used are currently only available in that language. Although the trial is not yet recruiting participants, those who take part can expect to help improve pregnancy care by providing valuable information that may lead to better health strategies for at-risk pregnancies.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Age: 21 years old to 50 years old
  • Singleton Pregnancy
  • No more than 13 weeks' and 6 days' gestation at recruitment
  • Able to provide written, informed consent
  • Exclusion Criteria:
  • Not proficient in the English language (AI intervention is only available in English at this stage)

About National University Hospital, Singapore

National University Hospital (NUH) in Singapore is a leading academic medical institution dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, NUH emphasizes a multidisciplinary approach, integrating cutting-edge medical research with high-quality patient care. The hospital collaborates with various stakeholders, including academic institutions and industry partners, to explore new therapies and improve treatment outcomes across a wide range of medical disciplines. Committed to ethical standards and patient safety, NUH plays a pivotal role in shaping the future of medicine in Singapore and beyond.

Locations

Singapore, , Singapore

Patients applied

0 patients applied

Trial Officials

Sarah Li, MRCOG, MPH

Principal Investigator

National University Hospital, Singapore

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported